Nanoformulation of BRD4-Degrading PROTAC: Improving Druggability To Target the ‘Undruggable’ MYC in Pancreatic Cancer
Publication date: Available online 4 September 2020Source: Trends in Pharmacological SciencesAuthor(s): Tamara Minko
Source: Trends in Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Nanotechnology | Pancreas | Pancreatic Cancer